181 related articles for article (PubMed ID: 35551324)
1. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
Miller L; Prieto Merino D; Baisley K; Hayes R
PLoS One; 2022; 17(5):e0267011. PubMed ID: 35551324
[TBL] [Abstract][Full Text] [Related]
2. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
[TBL] [Abstract][Full Text] [Related]
3. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
4. Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035).
Gorbach PM; Kelly CW; Borgerding JA; Ramjee G; Tembo T; Kumwenda N; Musara P; Roberts S; Maslankowski L
AIDS Behav; 2014 May; 18(5):855-61. PubMed ID: 24158488
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
Whitehead SJ; McLean C; Chaikummao S; Braunstein S; Utaivoravit W; van de Wijgert JH; Mock PA; Siraprapasiri T; Friedland BA; Kilmarx PH; Markowitz LE
PLoS One; 2011; 6(9):e14831. PubMed ID: 21915249
[TBL] [Abstract][Full Text] [Related]
6. Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.
Friedland BA; Stoner M; Chau MM; Plagianos MG; Govender S; Morar N; Altini L; Skoler-Karpoff S; Ahmed K; Ramjee G; Monedi C; Maguire R; Lähteenmäki P
AIDS Behav; 2016 Nov; 20(11):2565-2577. PubMed ID: 26204987
[TBL] [Abstract][Full Text] [Related]
7. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda.
Abaasa A; Crook A; Gafos M; Anywaine Z; Levin J; Wandiembe S; Nanoo A; Nunn A; McCormack S; Hayes R; Kamali A
Trials; 2013 Feb; 14():33. PubMed ID: 23374729
[TBL] [Abstract][Full Text] [Related]
8. Topical microbicides for prevention of sexually transmitted infections.
Obiero J; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
[TBL] [Abstract][Full Text] [Related]
9. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
[TBL] [Abstract][Full Text] [Related]
10. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
11. Topical microbicides for preventing sexually transmitted infections.
Obiero J; Ogongo P; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007961. PubMed ID: 33719075
[TBL] [Abstract][Full Text] [Related]
12. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
13. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.
Succop SM; MacQueen KM; van Loggerenberg F; Majola N; Karim QA; Karim SS
AIDS Care; 2014; 26(12):1521-5. PubMed ID: 25285564
[TBL] [Abstract][Full Text] [Related]
14. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
Abdulai MA; Baiden F; Adjei G; Afari-Asiedu S; Adjei K; Tawiah C; Newton S
BMC Womens Health; 2012 Nov; 12():40. PubMed ID: 23114222
[TBL] [Abstract][Full Text] [Related]
15. Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
PLoS One; 2021; 16(1):e0244652. PubMed ID: 33411782
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.
Montgomery ET; Noguchi LM; Dai JY; Pan J; Biggio J; Hendrix C; Isaacs K; Watts DH; Schwartz JL; Piper J; Beigi R
AIDS Behav; 2018 Feb; 22(2):402-411. PubMed ID: 28550377
[TBL] [Abstract][Full Text] [Related]
18. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
[TBL] [Abstract][Full Text] [Related]
19. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
